Adolescent obesity and risk for subsequent major depressive disorder and anxiety disorder: Prospective evidence

被引:203
|
作者
Anderson, Sarah E.
Cohen, Patricia
Naumova, Elena N.
Jacques, Paul F.
Must, Aviva
机构
[1] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA
[2] Tufts Univ, Sch Nutr Sci & Policy, Boston, MA 02111 USA
[3] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA
[4] New York State Psychiat Inst & Hosp, Dept Epidemiol, New York, NY 10032 USA
[5] Tufts Univ, Sch Med, Dept Publ Hlth & Family Med, Boston, MA 02111 USA
[6] Tufts Univ, Nutr Epidemiol Program, Boston, MA 02111 USA
[7] Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA
来源
PSYCHOSOMATIC MEDICINE | 2007年 / 69卷 / 08期
关键词
body mass index; depression; longitudinal study; obesity; prospective cohort; relative weight;
D O I
10.1097/PSY.0b013e31815580b4
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To assess whether adolescent obesity is associated with risk for development of major depressive disorder (MDD) or anxiety disorder. Obesity has been linked to psychosocial difficulties among youth. Methods: Analysis of a prospective community-based cohort originally from upstate New York, assessed four times over 20 years. Participants (n = 776) were 9 to 18 years old in 1983; subsequent assessments took place in 1985 to 1986 (n = 775), 1991 to 1994 (n = 776), and 2001 to 2003 (n = 661). Using Cox proportional hazards analysis, we evaluated the association of adolescent (age range, 12-17.99 years) weight status with risk for subsequent MDD or anxiety disorder (assessed at each wave by structured diagnostic interviews) in males and females. A total of 701 participants were not missing data on adolescent weight status and had >= 1 subsequent assessments. MDD and anxiety disorder analyses included 674 and 559 participants (free of current or previous MDD or anxiety disorder), respectively. Adolescent obesity was defined as body mass index above the age- and gender-specific 95th percentile of the Centers for Disease Control and Prevention growth reference. Results: Adolescent obesity in females predicted an increased risk for subsequent MDD (adjusted hazard ratio (HR) = 3.9; 95% confidence interval (CI) = 1.3, 11.8) and for anxiety disorder (HR = 3.8; Cl = 1.3, 11.3). Adolescent obesity in males was not statistically significantly associated with risk for MDD (HR = 1.5; CI = 0.5, 3.5) or anxiety disorder (HR = 0.7; CI = 0.2, 2.9). Conclusion: Females obese as adolescents may be at increased risk for development of depression or anxiety disorders.
引用
收藏
页码:740 / 747
页数:8
相关论文
共 50 条
  • [41] Treatment of Comorbid Obesity and Major Depressive Disorder: A Prospective Pilot Study for their Combined Treatment
    Faulconbridge, Lucy F.
    Wadden, Thomas A.
    Berkowitz, Robert I.
    Pulcini, Melissa E.
    Treadwell, Thomas
    JOURNAL OF OBESITY, 2011, 2011
  • [42] Course and outcome of child and adolescent major depressive disorder
    Birmaher, B
    Arbelaez, C
    Brent, D
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2002, 11 (03) : 619 - +
  • [43] Escitalopram: In the treatment of major depressive disorder in adolescent patients
    Yang L.P.H.
    Scott L.J.
    Pediatric Drugs, 2010, 12 (3) : 155 - 162
  • [44] Alexithymia and Emotional Intelligence in Patients with Panic Disorder, Generalized Anxiety Disorder and Major Depressive Disorder
    Elif Onur
    Tunc Alkın
    Michael J. Sheridan
    Thomas N. Wise
    Psychiatric Quarterly, 2013, 84 : 303 - 311
  • [45] Alexithymia and Emotional Intelligence in Patients with Panic Disorder, Generalized Anxiety Disorder and Major Depressive Disorder
    Onur, Elif
    Alkin, Tunc
    Sheridan, Michael J.
    Wise, Thomas N.
    PSYCHIATRIC QUARTERLY, 2013, 84 (03) : 303 - 311
  • [46] Alexithymia and emotional intelligence in patients with panic disorder, generalized anxiety disorder and major depressive disorder
    Onur, E.
    Alkin, T.
    Sheridan, M.
    Cimilli, C.
    Wise, T. N.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2008, 64 (06) : 666 - 666
  • [47] The network structure of major depressive disorder, generalized anxiety disorder and somatic symptomatology
    Bekhuis, E.
    Schoevers, R. A.
    van Borkulo, C. D.
    Rosmalen, J. G. M.
    Boschloo, L.
    PSYCHOLOGICAL MEDICINE, 2016, 46 (14) : 2989 - 2998
  • [48] Hemolacria secondary to major depressive disorder and generalized anxiety disorder: A case report
    Razeghian Jahromi, Leila
    Ghaderian Jahromi, Mehdi
    Ghavipisheh, Mahsa
    Ahrari, Iman
    CLINICAL CASE REPORTS, 2023, 11 (11):
  • [49] Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy?
    Gorwood, P
    EUROPEAN PSYCHIATRY, 2004, 19 (01) : 27 - 33
  • [50] Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
    Liebowitz, Michael
    Careri, Jason
    Blatt, Kyra
    Draine, Ann
    Hanover, Rita
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S365 - S366